Atlas market file ¡ Etf ¡ United States
iShares iBonds Dec 2031 Term Corporate ETFIBDW
- Last close
- 20.65
- Change
- +0.24%
- 96-bar range
- 20.55 â 21.105
- As of
- 7 Aug 2026
iShares iBonds Dec 2031 Term Corporate ETF is an exchange-traded fund listed as IBDW on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
⎠up candle ⎠down candle
Weekly outlook: the last 104 weekly closes (-1.99% over the window).
Source rail: Yahoo Finance chart API (IBDW). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView ¡ provider feed Open view ->
Open the attributed TradingView market view for IBDW. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
IBDW public profile
Exchange-traded fund. iShares iBonds Dec 2031 Term Corporate ETF is connected to current market context, cited company sources and its retained research file.
iShares iBonds Dec 2031 Term Corporate ETF trades as IBDW on AMEX. iShares iBonds Dec 2031 Term Corporate ETF (IBDW) has a latest verified close of 20.65, up 0.24%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. IBDW stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for iShares iBonds Dec 2031 Term Corporate ETF today
iShares iBonds Dec 2031 Term Corporate ETF (IBDW) is a five-year ladder of mostly unremarkable investment-grade corporate bonds that all happen to mature in a neat cluster around 31 December 2031, sold to you under the banner of âease and convenienceâ rather than the scintillating promise of capital gains. The wrapper is BlackRockâs iShares, the worldâs largest ETF issuer, but the actual product is a static, self-liquidating credit ladder wrapped in a 0.10% management fee that quietly erodes yield before the bonds even cough up their coupons. The fund trades on Nasdaq, where its daily liquidity is visible but unexciting, and its holdings are disclosed like a guest list at a municipal library opening rather than a blockbuster IPO. If you want a date you can pencil into a calendar, 2031 is it; if you want a story, youâll need to look elsewhere.
iShares sells the idea of thematic exposure-AI, innovation, growth-across its broader range, but IBDW sits in a quiet corner of the site where the only theme is the gradual expiry of its bonds. The fundâs product pages remind us that iShares by BlackRock is the largest provider of ETFs globally, which is impressive until you remember that âlargestâ is not the same as âmost exciting.â The issuerâs own disclaimers note that most protections of the UK regulatory system do not apply to its products and that compensation will not be available under the UK Financial Services Compensation Scheme in the event of default, which is corporate-speak for âyouâre on your own.â The fundâs AUM and liquidity figures are published by Nasdaq, but the headline is duller than a spreadsheet designed by an actuary in 1998.
The SEC EDGAR filing for IBDW confirms the fundâs static mandate and fixed maturity profile, with holdings disclosed in line with regulatory requirements. The expense ratio is 0.10% per year, a figure that sounds modest until you run the math over five years and realise it quietly consumes a meaningful slice of the natural yield in a low-rate world. The fundâs tracking method is straightforward: hold the bonds to maturity and let the cash roll in on schedule, like a pensioner collecting coupons while the rest of the market chases the next big narrative. The issuer marketing leans heavily on âindustry-leading researchâ and âexpert management,â but the actual product is closer to a filing trail stack than a rocket ship. BlackRockâs UK site also notes that most UK regulatory protections do not apply to iShares products, a disclosure that arrives with the force of a sigh rather than a warning siren.
Nasdaq lists IBDW with daily price and volume data, but the fundâs liquidity profile is what youâd expect from a term-maturity ladder: thin on excitement, heavy on predictability. The fundâs holdings are not actively traded; they simply age, pay, and roll off like a conveyor belt in a factory that stopped innovating in 2019. The issuerâs marketing materials elsewhere-such as the AI-themed pages-are best ignored for this product, because the fundâs mandate has no connection to artificial intelligence, innovation, or any other current thematic obsession. The fund is a time capsule of credit risk, not a bet on the future.
What changed this week? Nothing structural. The fundâs price on Nasdaq moves with the daily tide of credit spreads and rate expectations, but the underlying basket is unchanged unless an issuer calls a bond or a credit rating migrates. The evidence contains no earnings surprises, no product launches, and no material news flow tied to IBDW itself; the fundâs story is the slow march to 2031, not a sudden plot twist. The main source of ânewsâ is the daily price quote on Nasdaq and the quiet rotation of bonds as older issues mature and new ones enter the ladder, but these are mechanical events rather than market-moving developments.
What remains unproven? The fundâs long-term relative strength versus simply holding a ladder of individual bonds is largely a function of convenience and fee arbitrage rather than alpha. The issuerâs marketing suggests thematic exposure, but the fund offers none; the reality is a static credit ladder with a wrapper fee. The fundâs AUM is visible on Nasdaq, but the headline number is not large enough to move markets or to trigger meaningful analyst coverage. The fundâs expense ratio is low by ETF standards, but it is not zero, and in a world of near-zero yields, every basis point counts. The fundâs tracking method is transparent-hold to maturity-but the transparency is also the limitation: you know exactly what youâre getting, and itâs not much.
Sources & evidence ¡ 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
IBDW technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on IBDW
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep IBDW research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
IBDW FAQ
What is iShares iBonds Dec 2031 Term Corporate ETF (IBDW)?iShares iBonds Dec 2031 Term Corporate ETF (IBDW) has a latest verified close of 20.65, up 0.24%, dated 7 Aug 2026. Use this page to check the price chart, company...
iShares iBonds Dec 2031 Term Corporate ETF (IBDW) has a latest verified close of 20.65, up 0.24%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for IBDW?iShares iBonds Dec 2031 Term Corporate ETF (IBDW) has a latest verified close of 20.65, up 0.24%, dated 7 Aug 2026. It brings the latest available chart, company...
iShares iBonds Dec 2031 Term Corporate ETF (IBDW) has a latest verified close of 20.65, up 0.24%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. IBDW stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the IBDW page updated?The IBDW public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The IBDW public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for IBDW?The IBDW file starts with Nasdaq Trader and TradingView AMEX:IBDW. The page separates verified market context from company evidence and shows open evidence gaps instead...
The IBDW file starts with Nasdaq Trader and TradingView AMEX:IBDW. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on IBDW?Yes. The workstation can open IBDW, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open IBDW, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this IBDW page investment advice?No. The IBDW page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The IBDW page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes â
IBDW
Etf ¡ evidence first